GL1X · GenesisL1 explorer

Ligand · TB7

TB7 · Tert-butyl 3-[(4-oxo-3H-pyrido[2,3-d]pyrimidin-2-yl)amino]azetidine-1-carboxylate

TB7, Tert-butyl 3-[(4-oxo-3H-pyrido[2,3-d]pyrimidin-2-yl)amino]azetidine-1-carboxylate (C15 H19 N5 O3, 317.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5…

Component
TB7
Formula
C15 H19 N5 O3
Class
ligand
Structures
2
PDB entries
1

Binding sites

TB7 in 2 structures; the first of them:

  • 4AQH · Plasminogen activator inhibitor type-1 in complex with the inhibitor AZ3976 · TB7 A1380 · binds ALA12, TYR37, ALA40, SER41, ALA44, PHE64, ILE66, LEU75 and 9 more
  • 4AQH · Plasminogen activator inhibitor type-1 in complex with the inhibitor AZ3976 · TB7 A1380 · binds ALA12, TYR37, ALA40, SER41, ALA44, PHE64, ILE66, LEU75 and 9 more

Residues it binds most

ALA 6, LEU 6, ARG 6, PHE 6, THR 6, TYR 6, SER 6, ASP 6, ILE 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.